Free shipping on all U.S. orders over $250 · Local pickup available in Morgan Hill, CA
PureLab Performancepurelabperformance.com
Research compoundLongevity & Cellular ResearchIn stock

NAD+

Also known as: Nicotinamide adenine dinucleotide

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell. NAD+ biology is heavily researched, but most human studies raise NAD+ with precursors such as NR or NMN; studies of NAD+ itself in humans are small.

Evidence: limited · Small human pilot studies; biology well studied

At a glance

Class
Coenzyme (dinucleotide)
Developer
No pharmaceutical developer
FDA status
Not FDA-approved
Human data
Small open-label pilot and retrospective infusion studies (design-level only)
Animal / lab data
Mouse high-fat-diet model and hypothalamic cell work; large precursor literature

Where it’s been studied

123
  • 1BloodPlasma and urine NAD+ metabolome, human pilot (2019)
  • 2BrainDiurnal activity rhythms, high-fat-diet model, mouse (2018)
  • 3Cell studiesHypothalamic neuron cells, NAD depletion (2018)

Mechanism studied

NAD+ is a coenzyme for cellular redox reactions and is central to mitochondrial function [1]. Sirtuins, PARPs and CD38 consume NAD+, releasing nicotinamide that is recycled mainly through the NAMPT-driven salvage pathway, estimated to supply about 85% of NAD+ in mammals [2]. How directly supplied NAD+ is handled in the body is still being characterized; researchers have measured its plasma and urine metabolites in a small human pilot [3].

What the research shows

StudyModelReported resultSource
NAD+ metabolome during infusion [3]Human
Adults, open-label pilot; plasma and urine metabolites measured (see publication).
Endpoints: plasma and urine NAD+ and metabolites (nicotinamide, methylnicotinamide, ADPR, NMN). Published.Peer-reviewed
Frontiers in Aging Neuroscience 2019
Chronic NAD in high-fat-fed mice [5]Mouse
High-fat-diet model (12-week high-fat diet), C57BL/6 mice, NAD given in final 4 weeks; hypothalamic cells
Researchers reported body-weight and locomotor-rhythm measurements; abstract gives no effect sizes.Peer-reviewed
Obesity 2018
NAD+ metabolism and mitochondria [1]Review
Review of NAD+ metabolism, mitochondria and recent clinical trials
Summarizes NAD+ decline with age and research on precursor- and drug-based approaches to raise it.Peer-reviewed
npj Metabolic Health and Disease 2025
Targeting NAD homeostasis [2]Review
Review of NAD compartments, measurement and modulation
Covers NAD+-consuming enzymes, NAMPT salvage pathway, and precursor studies in mice and humans.Peer-reviewed
Metabolites 2026

Human trials are listed for research context only; outcomes are reported in the linked publications. Animal and lab results do not establish effects in humans.

Verified by third-party testing

CertificatePosted on the product page
TestingIndependent, third-party

Research-grade supply

PureLab supplies NAD+ for laboratory research. Lot-specific certificates of analysis are posted on the product page as they are issued.

View research-grade NAD+

More in Longevity & Cellular Research

Sources

  1. Yusri K et al. (2025). doi:10.1038/s44324-025-00067-0 Source
  2. Nobile M et al. (2026). doi:10.3390/metabo16050338 Source
  3. Grant R et al. (2019). doi:10.3389/fnagi.2019.00257 Source
  4. Reyna K et al. (2026). doi:10.3389/fragi.2026.1652582 Source
  5. Roh E et al. (2018). doi:10.1002/oby.22263 Source
For research use only. Not for human or veterinary use. Not a drug, food or cosmetic, and not intended to diagnose, treat, cure or prevent any disease. This library summarizes published research for educational purposes. PureLab Performance Inc.